Multiple myeloma survivor and patient advocate Valarie Traynham returns for part 2 to share her insights on what action can be taken to create change in clinical research inequities. Valarie dives into the critical need to raise awareness about disparities in access and representation. She offers actionable ideas for improving healthcare support, building trust, and empowering historically marginalized communities through education and inclusion.

We’re joined by Valarie Traynham, a multiple myeloma survivor and passionate patient advocate, for the first of a two-part episode in a conversation on equity in healthcare and clinical research. Valarie explores the historical and systemic roots of medical mistrust and how they continue to impact clinical trial participation among racially diverse communities and people with disabilities. She sheds light on the misconceptions that discourage participation and offers thoughtful solutions for building trust and improving access to clinical trials.

In Part 2 of our conversation with Dr. Breelyn Wilky and Dr. Christopher Lieu from the University of Colorado Cancer Center, we dive deeper into the patient experience and the innovation behind clinical trials. They share guidance on when to consider a trial during your cancer journey, what a “day in the life” looks like for trial participants, and how trials differ from standard treatments like chemotherapy or radiation.

We also explore the unique role of investigator-initiated trials—what they are, how they differ from pharmaceutical-sponsored studies, and why they’re essential for advancing personalized cancer care.

In the first of a two-part episode, we sit down with Dr. Breelyn Wilky and Dr. Christopher Lieu from the University of Colorado Cancer Center to explore the vital role of clinical trials in advancing cancer treatment. They break down common misconceptions around trial safety and effectiveness, and explain how participation can benefit both patients and the future of oncology. Whether you're considering a trial or just curious, their expert advice brings clarity and encouragement.

Edie Harrison returns to Campfires of Hope to share her unique journey with clinical trials. Diagnosed as NED since 2022, Edie didn't need a trial for treatment purposes. Instead, she researched and sought out a “circulating tumor DNA” clinical trial—a cutting-edge approach to monitoring and detecting the return of her original cancer. Listen to Edie’s story to discover how clinical trials are transforming cancer care beyond treatment.

Diagnosed with leiomyosarcoma in 2015, Sarah Fay's journey to being NED nearly a decade later highlights the life-saving potential of clinical trials. In this Campfires of Hope: Stories of Cancer episode, Sarah shares an honest and inspiring account of her experience—from navigating complex logistics to managing the emotional challenges. Tune in to explore the transformative impact of clinical trials and her story of resilience.

Multiple cancer survivor Lana Boes returns to Campfires of Hope to share a detailed account of her journey through clinical trials and inspire others to take charge of their health. Lana opens up about the mental and emotional challenges of facing a recurrence in May, after five years of being NED (No Evidence of Disease), and how the strength of her community helped her rediscover her light.

In this episode of Campfires of Hope, cancer survivors Janna Jones and Eileen VanCleave open up about the deeply human experience of compassion fatigue. We explore what it is, why acknowledging it matters, and how it affects survivors, caregivers, and those in helping roles. Janna and Eileen offer heartfelt insights on self-care, forgiveness, and the power of sharing the load. This candid conversation is a powerful reminder that stepping back is not a weakness—it’s a sometimes necessary act of strength.

Learn more about how Epic Experience empowers cancer survivors to live beyond cancer at www.epicexperience.org